Join Dr. Idan Redenski for a discussion on the use of high-resolution microCT to assess vascular development and bone turnover when fabricating composite tissue flaps.

Functional regeneration of complex large-scaled defects requires both soft and hard tissue grafts. Autologous tissue-harvest, considered as the standard of care in clinical settings, possess major procedural drawbacks.

In this webinar, Dr. Redenski describes how they employ a tissue engineering approach based on biological tissue constructs in order to fabricate composite tissue flaps by combining synthetic soft-tissue matrices and biological bone matrix. He goes on to share how high-resolution microCT was used, both ex vivo and in vivo, to evaluate vascular development and bone turnover.

Key Topics Include:

  • Contrast-agent perfusion
  • In vivo microCT scans
  • High resolution vascular imaging

Who Should Attend?

This webinar will be of particular interest to preclinical researchers who specialize in cardiovascular-, neurovascular-, and oncology, as well as contract research organizations.


Galilee Medical Centre

Dr. Idan Redenski holds a dual degree in DMD-MSc specializing in microbial biofilms and laser therapy from the Hebrew University. Following that, in 2016, Idan began his PhD work in biomedical engineering at the Technion Institute of Technology, under the supervision of Professor Shulamit Levenberg. His research focused on stem-cell based vascularization and ECM based vascularized composite tissue fabrication. Most recently, in 2021, Dr. Redenski began a research-oriented residency in oral and maxillofacial surgery at the Galilee Medical Centre, with a focus on regenerative medicine and 3D-bioprinting.

Webinar Host

Bruker Corporation

Bruker offers preclinical imaging solutions for a broad spectrum of application fields, such as cancer research, neuroimaging and cardiac disease.

Additional Content From Bruker Corporation

Related Content